Expression of MMP-2, -9 and -13 in cell lines and fresh biopsies of squamous cell carcinomas of the upper aerodigestive tract

Anticancer Research

Volumn 23, Issue 3 B, 2003, Pages 2233-2239

  Dünne, Anja A ^a   Sesterhenn, A ^a   Gerisch, A ^a   Teymoortash, A ^a   Kuropkat, C ^a   Werner, J A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Matrix metalloproteinases; MMP 13; MMP 2; MMP 9; Squamous cell carcinoma

Indexed keywords

COLLAGENASE 3; GELATINASE A; GELATINASE B;

ARTICLE; BIOPSY TECHNIQUE; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HYBRIDIZATION; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; UPPER GASTROINTESTINAL TRACT;

ADULT; AGED; BIOPSY; CARCINOMA, SQUAMOUS CELL; COLLAGENASES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM STAGING; TUMOR CELLS, CULTURED;

EID: 0041806467     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kossakowska AE, Hutchcroft SA, Urbanski SJ and Edwards DR: Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans. Br J Cancer 73: 1401-1408, 1996.
2. Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana, CD, Guo F, Liu D, Kemp B, Lee JJ, Hong WK and Fidler IJ: Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma. Clin Cancer Res 6: 790-797, 2000.
3. Kanayama H: Matrix metalloproteinases and bladder cancer. J Med Invest 48: 31-43, 2001.
4. O'charoenrat P, Rhys-Evans PH and Eccles SA: Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 813-820, 2001.
5. Pendas AM, Uria JA, Jiménez MG, Balbin M, Freije J and Lopez-Otin C: An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin Chim Acta 291: 137-155, 2000.
6. King WG, Mattaliano MD and Brugge JS: Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf1/mitogen-activated protein kinase pathway activation. Mol Cell Biol 17: 4406-4418, 1997.
7. Werner JA, Rathcke IO and Mandic R: The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 19: 275-282, 2002.
8. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J and Kähäri VM: Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 208: 387-397, 1997.
9. Johansson N, Airola K, Grénman R, Kariniemi AL, Saarialho-Kere U and Kähäri VM: Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151: 499-508, 1997.
10. Etoh T, Inoue H, Yoshikawa Y, Barnard GF, Kitano S and Mori M: Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness. Gut 47: 50-56, 2000.
11. Stahle-Bäckdahl M, Sandstedt B, Bruce K, Lindahl A, Jimeney MG, Vega JA and Lopez-Otin C: Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 76: 717-728, 1997.
12. Shima I, Sasaguri Y, Kusukawa J, Yamana H, Fujita H, Kakegawa T and Morimatsu M: Production of matrix metalloproteinase-2 und metalloproteinase-3 related to malignant behaviour of esophageal carcinoma. Cancer 70: 2747-2753, 1992.
13. Charous SJ, Stricklin GP, Nanney LB, Netterville JL and Burkey BB: Expression of metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 106: 271-278, 1997.
14. Kawata R, Shimada T, Maruyama S, Hisa Y, Takenaka H and Murakami Y: Enhanced production of matrix metalloproteinase-2 in human head and neck carcinomas is correlated with lymph node metastasis. Acta Otolaryngol 122: 101-106, 2002.
15. Pickett KL, Harber GJ, DeCarlo AA, Louis P, Shaneyfelt S, Windsor LJ and Bodden MK: 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro. J Dent Res 78: 1354-1361, 1999.
16. Tokumaru Y, Fujii M, Otani Y, Kameyama K, Imanishi Y, Igarashi N and Kanzaki J: Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma: studies of clinical samples and in cell lines co-cultured with fibroblasts. Cancer Lett 150: 15-21, 2000.
17. Hong SD, Hong SP, Lee JI and Lim CY: Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 36: 207-213, 2000.
18. Yorioka CW, Coletta RD, Alves F, Nishimoto IN, Kowalski LP and Graner E: Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients. Int J Oncol 20: 189-194, 2002.
19. Collins SJ, Gallo RC and Gallagher RE: Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270: 347-349, 1977.
20. Gallagher RE, Collins SJ, Trujillo J, McCredie K, Ahearn M, Tsai S, Metzgar G, Aulakh G, Ting F, Ruscetti F and Gallo RC: Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood 54: 713-33, 1979.
21. Schwatsmann G, Pinedo HM and Leyva A: Resistance of HL-60 promyelocytic leukemia cells to induction of differentiation and its reversal by combination treatment. Eur J Cancer Clin Oncol 23: 739-743, 1987.
22. Kuropkat C, Plehn S, Herz U, Dunne AA, Renz H and Werner JA: Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer. Anticancer Res 22: 2221-2227, 2002.
23. Airola K, Johansson N, Kariniemi AL, Kähäri VM and Saarialho-Kere U: Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 109: 225-231, 1997.
24. Airola K, Karonen T, Vaalamo M, Lehti K, Lohi J, Kariniemi AL, Keski-Oja J and Saarialho-Kere UK: Expression of collagenases-1 and -3 and their inhibitors TIMP-1. and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 80: 733-743, 1999.
25. Johansson N, Vaalamo M, Grénman S, Hietanen S, Klemi P, Saarialho-Kere U and Kähäri VM: Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 154: 469-480, 1999.
26. Uria A, Stahle-Bäckdahl M, Seiki M, Fueyo A and Lopez-Otin C: Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 57: 4882-4888, 1997
27. Uria JA, Balbin M, Lopez J.M, Alvarez J, Vizoso F, Takigawa M and Lopez-Otin C: Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 153: 91-101, 1998.